Systemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis

References

• Feigin V, Nguyen G, Cercy K, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med. 2018;379:2429–2437.30575491
   PubMed Web of Science ®Google Scholar
• Phipps M, Cronin CJB. Management of acute ischemic stroke. BMJ. 2020;368:l6983. doi:10.1136/bmj.l698332054610
   PubMed Web of Science ®Google Scholar
• Powers WJ. Acute ischemic stroke. N Engl J Med. 2020;383:252–260. doi:10.1056/NEJMcp191703032668115
   PubMed Web of Science ®Google Scholar
• Jampathong N, Laopaiboon M, Rattanakanokchai S, et al. Prognostic models for complete recovery in ischemic stroke: a systematic review and meta-analysis. BMC Neurol. 2018;18:26. doi:10.1186/s12883-018-1032-529523104
   PubMed Web of Science ®Google Scholar
• Kim J, Park J, Chang J, et al. Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp Neurobiol. 2016;25:241–251. doi:10.5607/en.2016.25.5.24127790058
   PubMed Web of Science ®Google Scholar
• Cuadrado E, Ortega L, Hernández-Guillamon M, et al. Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release. J Leukocyte Biol. 2008;84:207–214. doi:10.1189/jlb.090760618390930
   PubMed Web of Science ®Google Scholar
• Jian Z, Liu R, Zhu X, et al. The involvement and therapy target of immune cells after ischemic stroke. Front Immunol. 2019;10:2167.31572378
   PubMed Web of Science ®Google Scholar
• Tsuyama J, Nakamura A, Ooboshi H, et al. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation. Semin Immunopathol. 2018;40:523–538. doi:10.1007/s00281-018-0707-830206661
   PubMed Web of Science ®Google Scholar
• Malone K, Amu S, Moore A, et al. The immune system and stroke: from current targets to future therapy. Immunol Cell Biol. 2019;97:5–16. doi:10.1111/imcb.1219130022515
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2020;146:692–698. doi:10.1002/ijc.3230330924141
   PubMed Web of Science ®Google Scholar
• Wang K, Diao F, Ye Z, et al. Prognostic value of systemic immune-inflammation index in patients with gastric cancer. Cancer Commun. . 2017;36:75.
   Google Scholar
• Huang X, Hu H, Zhang W, et al. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma. J Cell Physiol. 2019;234:18408–18414. doi:10.1002/jcp.2847630891768
   PubMed Web of Science ®Google Scholar
• Dong M, Shi Y, Yang J, et al. Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis. Ther Adv Med Oncol. 2020;12:1758835920937425.32699557
   PubMed Web of Science ®Google Scholar
• Pendlebury S, Rothwell P. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18:248–258. doi:10.1016/S1474-4422(18)30442-330784556
   PubMed Web of Science ®Google Scholar
• Khatri P, Abruzzo T, Yeatts S, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73:1066–1072. doi:10.1212/WNL.0b013e3181b9c84719786699
   PubMed Web of Science ®Google Scholar
• Rost N, Bottle A, Lee J, et al. Stroke severity is a crucial predictor of outcome: an international prospective validation study. J Am Heart Assoc. 2016;5. doi:10.1161/JAHA.115.002433
   Web of Science ®Google Scholar
• Swarowska M, Ferens A, Pera J, et al. Can prediction of functional outcome after stroke be improved by adding fibrinogen to prognostic model? J Stroke Cerebrovasc Dis. 2016;25:2752–2755. doi:10.1016/j.jstrokecerebrovasdis.2016.07.02927503272
   PubMed Web of Science ®Google Scholar
• Parikh N, Merkler A, Iadecola CJS. Inflammation, autoimmunity, infection, and stroke: epidemiology and lessons from therapeutic intervention. Stroke. 2020;51:711–718. doi:10.1161/STROKEAHA.119.02415732078460
   PubMed Web of Science ®Google Scholar
• Wang L, Song Q, Wang C, et al. Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review. J Neurol Sci. 2019;406:116445.31521961
   PubMed Web of Science ®Google Scholar
• Huang G, Chen H, Wang Q, et al. High platelet-to-lymphocyte ratio are associated with post-stroke depression. J Affect Disord. 2019;246:105–111. doi:10.1016/j.jad.2018.12.01230578944
   PubMed Web of Science ®Google Scholar
• Jin P, Li X, Chen J, et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke. J Clin Neurosci. 2019;63:110–115. doi:10.1016/j.jocn.2019.01.02830737090
   PubMed Web of Science ®Google Scholar
• Yang Y, Wu C, Hsu P, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Investig. 2020;50:e13230.32291748
   PubMed Web of Science ®Google Scholar
• Anrather J, Iadecola CJ. Inflammation and stroke: an overview. Neurotherapeutics. 2016;13:661–670. doi:10.1007/s13311-016-0483-x27730544
   PubMed Web of Science ®Google Scholar
• Iadecola C, Anrather JJ. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796–808. doi:10.1038/nm.239921738161
   PubMed Web of Science ®Google Scholar
• Weisenburger-Lile D, Dong Y, Yger M, et al. Harmful neutrophil subsets in patients with ischemic stroke: association with disease severity. Neurol Neuroimmunol Neuroinflam. 2019;6:e571. doi:10.1212/NXI.0000000000000571
   PubMed Web of Science ®Google Scholar
• Jander S, Kraemer M, Schroeter M, et al. Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cerebral Blood Flow Metabol. 1995;15:42–51. doi:10.1038/jcbfm.1995.5
   PubMed Web of Science ®Google Scholar
• Petrone A, Eisenman R, Steele K, et al. Temporal dynamics of peripheral neutrophil and lymphocytes following acute ischemic stroke. Neurolog Sci. 2019;40:1877–1885. doi:10.1007/s10072-019-03919-y
   Web of Science ®Google Scholar
• Gan Y, Liu Q, Wu W, et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci USA. 2014;111:2704–2709. doi:10.1073/pnas.131594311124550298
   PubMed Web of Science ®Google Scholar
• Gill D, Veltkamp RJ. Dynamics of T cell responses after stroke. Curr Opin Pharmacol. 2016;26:26–32. doi:10.1016/j.coph.2015.09.00926452204
   PubMed Web of Science ®Google Scholar
• Chen Y, Xiao Y, Lin Z, et al. The role of circulating platelets microparticles and platelet parameters in acute ischemic stroke patients. J Stroke Cerebrovascular Dis. 2015;24:2313–2320. doi:10.1016/j.jstrokecerebrovasdis.2015.06.018
   PubMed Web of Science ®Google Scholar
• Simon D, Chen Z, Xu H, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000;192:193–204. doi:10.1084/jem.192.2.19310899906
   PubMed Web of Science ®Google Scholar
• Denorme F, Manne B, Portier I, et al. Platelet necrosis mediates ischemic stroke outcome in mice. Blood. 2020;135:429–440. doi:10.1182/blood.201900212431800959
   PubMed Web of Science ®Google Scholar
• Xu J, He X, Li Q, et al. Higher platelet-to-lymphocyte ratio is associated with worse outcomes after intravenous thrombolysis in acute ischaemic stroke. Front Neurol. 2019;10:1192.31798520
   PubMed Web of Science ®Google Scholar
• Shantsila E, Lip GY. Stroke in atrial fibrillation and improving the identification of ‘high-risk’ patients: the crossroads of immunity and thrombosis. J Thromb Haemost. 2015;13:1968–197026303061
   PubMed Web of Science ®Google Scholar